Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?
A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium Chlamydia pneumoniae and human herpes...
Gespeichert in:
Veröffentlicht in: | Journal of Neuroimmunology 2003-03, Vol.136 (1), p.1-8 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8 |
---|---|
container_issue | 1 |
container_start_page | 1 |
container_title | Journal of Neuroimmunology |
container_volume | 136 |
creator | Swanborg, Robert H Whittum-Hudson, Judith A Hudson, Alan P |
description | A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium
Chlamydia pneumoniae and human herpes virus 6 (HHV-6) in the pathogenesis of MS. However, as is the case for essentially all earlier microbial associations, experimental evidence linking either this bacterium or this virus to MS is equivocal. We review the published reports concerning involvement of
C. pneumoniae and HHV-6 in MS, and data relating to possession of the
APOE ε4 allele, which some studies indicate might influence how these or other pathogens affect disease genesis. Based on the large set of inconsistent observations available and given important new information regarding the neuropathology of MS, we contend that no conclusion is possible at this point regarding the potential role of either
C. pneumoniae or HHV-6 in MS. We therefore propose future studies that should clarify whether, and if so how, these and other organisms function in the pathogenesis of this disease. |
doi_str_mv | 10.1016/S0165-5728(02)00465-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73081491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165572802004654</els_id><sourcerecordid>73081491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-744794ca815badd39372244676dbe47dc673d80b0bda7091ce410e0a69f9f8653</originalsourceid><addsrcrecordid>eNqFkc9q3DAQxkVJaLZpH6HBp9AenI7-WLJPoSxtEwjkkPYsZGncVbFlR7IXcutD9AnzJFF2l_SYywwDv2-G-T5CPlK4oEDll7tcqrJSrP4E7DOAyJN4Q1a0VqysBaNHZPWCnJB3Kf0BoBUXzVtyQplkILlake46dGhnPy6pML8xzLkFVwxLP_upxyLZHuOYfHr8-89ELNab3gwPzptiCrgMY_AGd4rNMphQbDBOmIqtj3mfLHzYjv0W3eV7ctyZPuGHQz8lv75_-7m-Km9uf1yvv96UtqIwl0oI1Qhralq1xjnecMWYEFJJ16JQzkrFXQ0ttM4oaKhFQQHByKZrulpW_JSc7_dOcbxfMM168Mli35uA-UWtONRUNPRVMNvIheI8g9UetNmGFLHTU_SDiQ-agn5OQu-S0M82a2B6l4QWWXd2OLC0A7r_qoP1GbjcA5j92HqMOlmPwaLzMSei3ehfOfEEMUSZyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18734733</pqid></control><display><type>article</type><title>Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Swanborg, Robert H ; Whittum-Hudson, Judith A ; Hudson, Alan P</creator><creatorcontrib>Swanborg, Robert H ; Whittum-Hudson, Judith A ; Hudson, Alan P</creatorcontrib><description>A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium
Chlamydia pneumoniae and human herpes virus 6 (HHV-6) in the pathogenesis of MS. However, as is the case for essentially all earlier microbial associations, experimental evidence linking either this bacterium or this virus to MS is equivocal. We review the published reports concerning involvement of
C. pneumoniae and HHV-6 in MS, and data relating to possession of the
APOE ε4 allele, which some studies indicate might influence how these or other pathogens affect disease genesis. Based on the large set of inconsistent observations available and given important new information regarding the neuropathology of MS, we contend that no conclusion is possible at this point regarding the potential role of either
C. pneumoniae or HHV-6 in MS. We therefore propose future studies that should clarify whether, and if so how, these and other organisms function in the pathogenesis of this disease.</description><identifier>ISSN: 0165-5728</identifier><identifier>EISSN: 1872-8421</identifier><identifier>DOI: 10.1016/S0165-5728(02)00465-4</identifier><identifier>PMID: 12620637</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Apolipoprotein E4 ; Apolipoproteins E - genetics ; Apolipoproteins E - immunology ; Chlamydia pneumoniae ; Chlamydophila Infections - complications ; Chlamydophila pneumoniae - immunology ; Chlamydophila pneumoniae - pathogenicity ; Genetic Predisposition to Disease ; Herpesvirus 6, Human - immunology ; Herpesvirus 6, Human - pathogenicity ; Human herpes virus-6 ; Humans ; Molecular Mimicry - immunology ; Multiple sclerosis ; Multiple Sclerosis - genetics ; Multiple Sclerosis - immunology ; Multiple Sclerosis - microbiology ; Oligodendroglia - immunology ; Oligodendroglia - microbiology ; Roseolovirus Infections - complications</subject><ispartof>Journal of Neuroimmunology, 2003-03, Vol.136 (1), p.1-8</ispartof><rights>2002 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-744794ca815badd39372244676dbe47dc673d80b0bda7091ce410e0a69f9f8653</citedby><cites>FETCH-LOGICAL-c510t-744794ca815badd39372244676dbe47dc673d80b0bda7091ce410e0a69f9f8653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0165-5728(02)00465-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>313,314,776,780,788,3536,27901,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12620637$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Swanborg, Robert H</creatorcontrib><creatorcontrib>Whittum-Hudson, Judith A</creatorcontrib><creatorcontrib>Hudson, Alan P</creatorcontrib><title>Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?</title><title>Journal of Neuroimmunology</title><addtitle>J Neuroimmunol</addtitle><description>A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium
Chlamydia pneumoniae and human herpes virus 6 (HHV-6) in the pathogenesis of MS. However, as is the case for essentially all earlier microbial associations, experimental evidence linking either this bacterium or this virus to MS is equivocal. We review the published reports concerning involvement of
C. pneumoniae and HHV-6 in MS, and data relating to possession of the
APOE ε4 allele, which some studies indicate might influence how these or other pathogens affect disease genesis. Based on the large set of inconsistent observations available and given important new information regarding the neuropathology of MS, we contend that no conclusion is possible at this point regarding the potential role of either
C. pneumoniae or HHV-6 in MS. We therefore propose future studies that should clarify whether, and if so how, these and other organisms function in the pathogenesis of this disease.</description><subject>Apolipoprotein E4</subject><subject>Apolipoproteins E - genetics</subject><subject>Apolipoproteins E - immunology</subject><subject>Chlamydia pneumoniae</subject><subject>Chlamydophila Infections - complications</subject><subject>Chlamydophila pneumoniae - immunology</subject><subject>Chlamydophila pneumoniae - pathogenicity</subject><subject>Genetic Predisposition to Disease</subject><subject>Herpesvirus 6, Human - immunology</subject><subject>Herpesvirus 6, Human - pathogenicity</subject><subject>Human herpes virus-6</subject><subject>Humans</subject><subject>Molecular Mimicry - immunology</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - genetics</subject><subject>Multiple Sclerosis - immunology</subject><subject>Multiple Sclerosis - microbiology</subject><subject>Oligodendroglia - immunology</subject><subject>Oligodendroglia - microbiology</subject><subject>Roseolovirus Infections - complications</subject><issn>0165-5728</issn><issn>1872-8421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9q3DAQxkVJaLZpH6HBp9AenI7-WLJPoSxtEwjkkPYsZGncVbFlR7IXcutD9AnzJFF2l_SYywwDv2-G-T5CPlK4oEDll7tcqrJSrP4E7DOAyJN4Q1a0VqysBaNHZPWCnJB3Kf0BoBUXzVtyQplkILlake46dGhnPy6pML8xzLkFVwxLP_upxyLZHuOYfHr8-89ELNab3gwPzptiCrgMY_AGd4rNMphQbDBOmIqtj3mfLHzYjv0W3eV7ctyZPuGHQz8lv75_-7m-Km9uf1yvv96UtqIwl0oI1Qhralq1xjnecMWYEFJJ16JQzkrFXQ0ttM4oaKhFQQHByKZrulpW_JSc7_dOcbxfMM168Mli35uA-UWtONRUNPRVMNvIheI8g9UetNmGFLHTU_SDiQ-agn5OQu-S0M82a2B6l4QWWXd2OLC0A7r_qoP1GbjcA5j92HqMOlmPwaLzMSei3ehfOfEEMUSZyg</recordid><startdate>20030301</startdate><enddate>20030301</enddate><creator>Swanborg, Robert H</creator><creator>Whittum-Hudson, Judith A</creator><creator>Hudson, Alan P</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20030301</creationdate><title>Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?</title><author>Swanborg, Robert H ; Whittum-Hudson, Judith A ; Hudson, Alan P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-744794ca815badd39372244676dbe47dc673d80b0bda7091ce410e0a69f9f8653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Apolipoprotein E4</topic><topic>Apolipoproteins E - genetics</topic><topic>Apolipoproteins E - immunology</topic><topic>Chlamydia pneumoniae</topic><topic>Chlamydophila Infections - complications</topic><topic>Chlamydophila pneumoniae - immunology</topic><topic>Chlamydophila pneumoniae - pathogenicity</topic><topic>Genetic Predisposition to Disease</topic><topic>Herpesvirus 6, Human - immunology</topic><topic>Herpesvirus 6, Human - pathogenicity</topic><topic>Human herpes virus-6</topic><topic>Humans</topic><topic>Molecular Mimicry - immunology</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - genetics</topic><topic>Multiple Sclerosis - immunology</topic><topic>Multiple Sclerosis - microbiology</topic><topic>Oligodendroglia - immunology</topic><topic>Oligodendroglia - microbiology</topic><topic>Roseolovirus Infections - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swanborg, Robert H</creatorcontrib><creatorcontrib>Whittum-Hudson, Judith A</creatorcontrib><creatorcontrib>Hudson, Alan P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Neuroimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swanborg, Robert H</au><au>Whittum-Hudson, Judith A</au><au>Hudson, Alan P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved?</atitle><jtitle>Journal of Neuroimmunology</jtitle><addtitle>J Neuroimmunol</addtitle><date>2003-03-01</date><risdate>2003</risdate><volume>136</volume><issue>1</issue><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>0165-5728</issn><eissn>1872-8421</eissn><abstract>A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium
Chlamydia pneumoniae and human herpes virus 6 (HHV-6) in the pathogenesis of MS. However, as is the case for essentially all earlier microbial associations, experimental evidence linking either this bacterium or this virus to MS is equivocal. We review the published reports concerning involvement of
C. pneumoniae and HHV-6 in MS, and data relating to possession of the
APOE ε4 allele, which some studies indicate might influence how these or other pathogens affect disease genesis. Based on the large set of inconsistent observations available and given important new information regarding the neuropathology of MS, we contend that no conclusion is possible at this point regarding the potential role of either
C. pneumoniae or HHV-6 in MS. We therefore propose future studies that should clarify whether, and if so how, these and other organisms function in the pathogenesis of this disease.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>12620637</pmid><doi>10.1016/S0165-5728(02)00465-4</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0165-5728 |
ispartof | Journal of Neuroimmunology, 2003-03, Vol.136 (1), p.1-8 |
issn | 0165-5728 1872-8421 |
language | eng |
recordid | cdi_proquest_miscellaneous_73081491 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Apolipoprotein E4 Apolipoproteins E - genetics Apolipoproteins E - immunology Chlamydia pneumoniae Chlamydophila Infections - complications Chlamydophila pneumoniae - immunology Chlamydophila pneumoniae - pathogenicity Genetic Predisposition to Disease Herpesvirus 6, Human - immunology Herpesvirus 6, Human - pathogenicity Human herpes virus-6 Humans Molecular Mimicry - immunology Multiple sclerosis Multiple Sclerosis - genetics Multiple Sclerosis - immunology Multiple Sclerosis - microbiology Oligodendroglia - immunology Oligodendroglia - microbiology Roseolovirus Infections - complications |
title | Infectious agents and multiple sclerosis—are Chlamydia pneumoniae and human herpes virus 6 involved? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A58%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infectious%20agents%20and%20multiple%20sclerosis%E2%80%94are%20Chlamydia%20pneumoniae%20and%20human%20herpes%20virus%206%20involved?&rft.jtitle=Journal%20of%20Neuroimmunology&rft.au=Swanborg,%20Robert%20H&rft.date=2003-03-01&rft.volume=136&rft.issue=1&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=0165-5728&rft.eissn=1872-8421&rft_id=info:doi/10.1016/S0165-5728(02)00465-4&rft_dat=%3Cproquest_cross%3E73081491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18734733&rft_id=info:pmid/12620637&rft_els_id=S0165572802004654&rfr_iscdi=true |